These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Treatment of paraproteinemia]. Myśliwiec M; Zalewski G Pol Arch Med Wewn; 2004 Oct; 112 Spec No():71-80. PubMed ID: 15669204 [TBL] [Abstract][Full Text] [Related]
23. [Clinical aspects of monoclonal gammopathies in diseases of the lympho-plasmacytic cell system]. Westerhausen M Acta Med Austriaca; 1982; 9(4):143-9. PubMed ID: 6814157 [TBL] [Abstract][Full Text] [Related]
24. Light chain myeloma in a patient with thyroid carcinoma. Lin CS; Ho CL Ann Hematol; 2008 Feb; 87(2):163-4. PubMed ID: 17710397 [No Abstract] [Full Text] [Related]
25. Acute renal failure associated with a malignant lymphoproliferative disorder with monoclonal light chain immunoglobulin production. Report of a case. Berkel J; Granillo-Bodansky C; v d Borne AE Scand J Haematol; 1978 Apr; 20(4):377-83. PubMed ID: 418498 [TBL] [Abstract][Full Text] [Related]
27. [A plasmacytoma with changing paraproteinemia]. Heilmann E; Schuckall A; Intorp H Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(6):750-3. PubMed ID: 85587 [TBL] [Abstract][Full Text] [Related]
28. Plasma exchange therapy in acute renal failure due to light chain myeloma. Zucchelli P; Pasquali S; Cagnoli L; Rovinetti C Trans Am Soc Artif Intern Organs; 1984; 30():36-9. PubMed ID: 6442807 [No Abstract] [Full Text] [Related]
29. [The kidney in dysproteinemia]. Spanti D; Marcantoni C; Di Landro D G Ital Nefrol; 2005; 22 Suppl 33():S39-45. PubMed ID: 16419005 [TBL] [Abstract][Full Text] [Related]
30. Crystalloid deposits in the kidney. Keller LS; Faull RJ; Smith P; Swift J; Bannister KM; Otto S; Peh CA Nephrology (Carlton); 2005 Feb; 10(1):81-3. PubMed ID: 15705186 [TBL] [Abstract][Full Text] [Related]
31. [Lichen myxedematosus and multiple myeloma type IgG/kappa]. Krebs A; Müller A Hautarzt; 1980 Dec; 31(12):649-53. PubMed ID: 6782039 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis. Bochtler T; Hegenbart U; Heiss C; Benner A; Cremer F; Volkmann M; Ludwig J; Perz JB; Ho AD; Goldschmidt H; Schonland SO Haematologica; 2008 Mar; 93(3):459-62. PubMed ID: 18287137 [TBL] [Abstract][Full Text] [Related]
33. How lab staff and the estimation of free light chains can combine to aid the diagnosis of light chain disease. Sinclair D; Wainwright L Clin Lab; 2007; 53(5-6):267-71. PubMed ID: 17605400 [TBL] [Abstract][Full Text] [Related]
34. [IgD myeloma. Considerations about its diagnosis based on three cases (author's transl)]. López-Aldeguer J; Redón J; González-Molina J; Benedito M; Herranz C; Lacruz J; Navarro JR; Caballero M Sangre (Barc); 1981; 26(6):1139-44. PubMed ID: 6805083 [No Abstract] [Full Text] [Related]
35. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Abbott KC; Agodoa LY Clin Nephrol; 2001 Sep; 56(3):207-10. PubMed ID: 11597035 [TBL] [Abstract][Full Text] [Related]
36. Renal failure as the presenting feature of light chain myeloma of kappa type. Raina V; Veluchamy K; Kumar R; Malaviya AN J Assoc Physicians India; 1982 Sep; 30(9):636-8. PubMed ID: 6820955 [No Abstract] [Full Text] [Related]
37. [Plasmapheresis treatment in multiple myeloma with kidney insufficiency]. Blumberg A; Bürgi W; Marti HR Schweiz Med Wochenschr; 1983 Mar; 113(11):398-402. PubMed ID: 6844898 [TBL] [Abstract][Full Text] [Related]